Skip to main content

. 1966 Sep 10;2(5514):624–625. doi: 10.1136/bmj.2.5514.624

Treatment of refractory obesity with fenfluramine.

J F Munro, D A Seaton, L J Duncan

PMCID: PMC1943487 PMID: 5331182

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DUNCAN E. H., HYDE C. A., REGAN N. A., SWEETMAN B. A PRELIMINARY TRIAL OF FENFLURAMINE IN GENERAL PRACTICE. Br J Clin Pract. 1965 Aug;19:451–452. [PubMed] [Google Scholar]
DUNCAN L. J., ROSE K., MEIKLEJOHN A. P. Phenmetrazine hydrochloride and methylcellulose in the treatment of "refractory" obesity. Lancet. 1960 Jun 11;1(7137):1262–1265. doi: 10.1016/s0140-6736(60)92249-2. [DOI] [PubMed] [Google Scholar]
LEDOUAREC J. C., SCHMITT H. COMPARAISON PHARMACOLOGIQUE DE SEPT M'EDICAMENTS ANOREXIG'ENES. Therapie. 1964 Jul-Aug;19:831–841. [PubMed] [Google Scholar]
SEATON D. A., DUNCAN L. J., ROSE K., SCOTT A. M. Diethyl-propion in the treatment of "refractory" obesity. Br Med J. 1961 Apr 8;1(5231):1009–1011. doi: 10.1136/bmj.1.5231.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
SEATON D. A., ROSE K., DUNCAN L. J. CURRENT THERAPEUTICS. 203. SUSTAINED-ACTION CHLORPHENTERMINE IN THE CORRECTION OF REFRACTORY OBESITY. Practitioner. 1964 Nov;193:698–702. [PubMed] [Google Scholar]
Traherne J. B. A clinical trial of fenfluramine. Practitioner. 1965 Nov;195(169):677–680. [PubMed] [Google Scholar]

ACTIONS

RESOURCES